Clinical Research Fund

The Clinical Research Fund is designed to support cutting-edge clinical studies of new therapeutic options for Parkinson’s patients as well as research comparing the effectiveness of existing treatment options. Each year, NPF, under the direction of our Clinical and Scientific Advisory Board (CSAB), supports forward-looking research conducted by the world's top Parkinson’s disease (PD) experts. The singular aim of NPF’s Clinical Research Fund is our most effective way to partner with our Centers of Excellence to discover the best treatment and care options for people living with Parkinson’s disease

Click here to view the members of NPF's Clinical and Scientific Advisory Board.

The pie chart below illustrates broad areas of research that we fund within the Centers of Excellence. The funding categories represent projects in multiple areas, focused on improving care for Parkinson's patients.

Annual Funding Process

  • Request for Applications ("RFAs") are issued as funding becomes available, but no less than once per year.
  • Applications are accepted from any principal investigator affiliated with a currently certified COE
  • Individual investigators at non-certified institutions are invited to apply as collaborators
  • All research is peer-reviewed by NPF’s Clinical and Scientific Advisory Board, (CSAB)
  • NPF no longer funds basic laboratory research.

For more information, please view the Request for Applications.

Click here to read the about the NPF-funded 2011 scientific and clinical outcomes grants: NPF Awards More Than $1 Million for Research.

Currently: 0 (0 ratings)

Print